Extended oral antibiotic prophylaxis eliminated UTIs after robot-assisted radical cystectomy procedures. Prophylactic ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab)-based perioperative regimen has been approved by the European ...

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...

Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...

Joseph Jacob, MD, discusses the promising impact of TAR-200.

Robot-assisted neobladder yields better perioperative and functional outcomes with similar long-term survival to open surgery ...

Radical cystectomy is a morbid operation, with 30–90-day morbidity rates in the 30–60% range, even at very experienced centers. [3–5] Moreover, the 30–90-day mortality of radical ...

Cystectomy is a complex, three-part operation, consisting of bladder, prostate and seminal vesicle removal in men or excision of the bladder, uterus, adnexa and anterior vaginal wall in women ...

AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Discover the latest updates to the EAU guidelines for muscle-invasive and metastatic bladder cancer in 2025. Learn more.

In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...